InPharmX Inc., DBA University Learning Systems Phone: 1-800-940-5860 Email: info@universitylearning.com
Professional learning online at a desk
← All on demand pharmacology CE/CME

On demand pharmacology CE/CME

Patient Care Highlights

FormatSelf-paced onlineRecordedMay 19, 2026AccessAvailable now
Log in to register

About this course

Learn at your own pace.

  • This course provides 15 contact hours  of pharmacy CE and  (1.5 CEU) of live AAFP/ AMA PRA Category 1 Credit™, ACPE and pharmacology CE/CME credit.

  • Recorded in at the Hotel Brookmere in Saratoga Springs New York in May 19-21 2026

  • Term of Approval is from 04/28/2026 to 12/31/2026.

Educational information

Designed for meaningful, practical learning.

Sessions

Session
2026-05-19 Optimizing Drug Therapy and Avoiding Drug Injury in the Older Adult

Tuesday, May 19, 2026

Speaker: Dr. Reamer L. Bushardt Credit hours: 5 ACPE UAN: 0741-0000-26-009-H01-P

Learning objectives
  1. Topic Optimizing Drug Therapy and Avoiding Drug Injury in the Older Adult:
  2. At the conclusion of this program, the participant will be able to:
  3. Optimizing Drug Therapy and Avoiding Drug Injury in the Older Adult Part 1:
  4. Discuss key physiologic and pathophysiologic changes of aging that impact drug therapy
  5. Apply age-sensitive principles for medication dosing and management to patient scenarios.
  6. Optimizing Drug Therapy and Avoiding Drug Injury in the Older Adult: Part 2 :
  7. List nine key questions useful for identifying and managing inappropriate polypharmacy, such as unnecessary medication use in older adults
  8. Apply practical tools to screen and appropriately manage complex drug regimens among older adults with or at-risk for drug injury
  9. Discuss high-risk drug-drug and drug-dietary supplement interactions commonly encountered in primary care, including best practices in identifying and managing related toxicities.
2026-05-20 Current Practice Update: Opioids, Cannabinoids and Gabapentenoids for Managing Pain

Wednesday, May 20, 2026

Speaker: Dr. Gregory L. Holmquist Credit hours: 5 ACPE UAN: 0741-0000-26-010-H08-P

Learning objectives
  1. Discuss the burden of opioid misuse and abuse on the individual and society.
  2. Describe the fundamental concepts of pain management, including: a) addiction; b) tolerance; c) dependency; d) hyperalgesia; e) allodynia.
  3. State key principles for assessing patients in pain, identifying risk factors and behaviors that are associated with opioid misuse, abuse, and addiction.
  4. Describe the similarities and differences in the mechanism of action for opioids, cannabinoids and gabapentenoids.
  5. Compare and contrast the benefits, risks and role of opioids, cannabinoids and gabapentenoids in managing pain.
  6. Describe the best practice model for properly monitoring patients who are started on opioids, gabapentenoids and cannabinoids to minimize the risks of adverse reactions, over-dosage and inappropriate compliance.
  7. Compare and contrast the following product formulations of gabapentenoids with respect to their benefits and risks in managing pain: a) gabapentin (Neurontin); b) Horizant; c) Gralise; and, d) Lyrica.
  8. Compare and contrast the most common cannabinoids found in marijuana with regards to their benefits and risks in managing pain and other symptoms.
  9. 9.State the risks of combining opioids with: a) benzodiazepines; b) alcohol; c) gabapentenoids; and, d) cannabinoids.
  10. Describe how to counsel patients and caregivers regarding the safe use on naloxone for opioid overdose.
2026-05-21 Anxiety and Sleep Disorders: Drug and Non-Pharmacologic Considerations, Psychopharmacotherapy in Depression and Best Practices in Chronic Kidney Disease

Thursday, May 21, 2026

Speaker: Dr. Reamer L. Bushardt Credit hours: 5 ACPE UAN: 0741-0000-26-011-H01-P

Learning objectives
  1. Managing Anxiety and Sleep Disorders: Drug and Non-Pharmacologic Considerations-1
  2. Describe signs and symptoms of common sleep and anxiety disorders with a focus on older adults.
  3. Discuss common anxiety disorders, including the neurobiological basis of disease, clinical presentation, assessment, and approach to treatment.
  4. Recognize evidence-based treatments for insomnia and common anxiety disorders, including lifestyle, behavioral, and pharmacologic interventions.
  5. Identify key parameters that warrant referral to specialty care for individuals with insomnia and/or anxiety disorders. Optimizing Psychopharmacotherapy in Depression: Clinical Cases -
  6. Discuss pharmacologic management options within clinical cases of patients with depression.
  7. Relate physiologic and pathophysiologic alterations of brain neurochemistry to symptoms of depression, including the genetic link and molecular basis of injury.
  8. Apply clinical practice guidelines for antidepressant therapies.
  9. Describe key parameters for medications used to treat mechanism, safety, tolerability, efficacy, cost, and simplicity of use. Best Practices in Chronic Kidney
  10. Disease: Highlights from Latest Guidelines and Expert Recommendations
  11. Describe the latest evidence and expert consensus guidance for the evaluation and risk assessment of individuals with CKD.
  12. Discuss medications used to delay CKD progression and manage its complications, including mechanism of action, safety, tolerability, efficacy, price, and simplicity of use.
  13. Review strategies to identify and manage cardiovascular risk in individuals with CKD.
  14. Summarize key recommendations for primary care in the evaluation, prevention, and management of CKD.

Faculty

Portrait of Dr. Reamer L. Bushardt, ULS faculty member

Dr. Reamer L. Bushardt, PharmD, PA-C, DFAAPA

Provost and Vice President for Academic Affairs · MGH Institute of Health Professions

A professor and practicing primary-care PA whose work spans health-professions education, substance-use-disorder training, and clinical leadership.

Professional profile ↗
Portrait of Dr. Gregory L. Holmquist, ULS faculty member

Dr. Gregory L. Holmquist, PharmD, CPE

Clinical Pharmacist and Pain Educator

A clinician and educator with specialized experience in oncology pharmacy, end-of-life care, pain education, and medication management.

Professional profile ↗

Accreditation

Target audience

Pharmacists, Nurse Practitioners, Physicians, Physician Assistants, Nurses

PHARMACISTS

  • University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. 
  • These programs are accredited for all pharmacists.
  • This course provides 15 hours or 1.5 CEUs.
  • Credit for this course expires on May 19, 2029.

PHYSICIANS

The American Academy of Family Physicians (AAFP) has reviewed Patient Care Highlights and deemed it acceptable for up to 15 Live AAFP Prescribed credit(s). Term of Approval is from May 19, 2026 to May 19, 2026 Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s) toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Osteopathic Association (AOA).‍ ‍ Continuing medical education (CME) activities approved for American Academy of Family Physicians (AAFP) credit are recognized by the American Osteopathic Association (AOA) as equivalent to AOA Category 2 credit. 

NURSES

  • This course provides 15 hours (1.5 CEU)
  • University Learning Systems is approved by the California Board of Registered Nursing, Provider Number CEP 11409, and CE Broker Tracking #50-11357:
  • University Learning Systems is approved by CE Broker for Florida, Georgia, Arkansas, District of Columbia, Georgia, New Mexico, and West Virginia, Boards of Nursing. 
  • The same hours submitted to renew NP certification may be submitted to a State Board of Nursing for re-licensure.

OTHER PROFESSIONS

  • CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.

  • CANADIAN PHARMACISTS:Canadian Council on Continuing Education in Pharmacy (CCCEP)accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). 

  • CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians

  • Other healthcare professionals should confirm acceptance and reporting requirements with their licensing or certification board

Requirements and reporting

  • University Learning Systems reports pharmacy credit through CPE Monitor using the participant’s eNABPID number and date of birth.
  • University Learning Systems is approved by CE Broker, for pharmacy, medicine and nursing for participating states,  Tracking #50-11357. Participant's state license number is required for reporting.
  • Credit is based on completed evaluations for registered sessions. 
  • Credit is awarded per session; partial session credit is not available, and breaks are excluded.
  • Other eligible participants receive an applicable statement of credit after completing the required documentation.

Review complete ULS accreditation statements →

Course fees

DescriptionPrice
Default 15 Hours$250

Begin today

Ready when you are.

Log in to register